Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
RAPT
RAPT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RAPT News
Investor Rights Law Firm Investigates Multiple Companies
3d ago
PRnewswire
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
3d ago
PRnewswire
Investor Rights Investigation: Multiple Company Transactions
Feb 06 2026
PRnewswire
RAPT Therapeutics Proposed Sale to GSK Under Investigation
Feb 05 2026
Businesswire
Investor Rights Law Firm Investigates Multiple Companies
Feb 02 2026
Globenewswire
Investigation Alerts for Multiple Company Mergers
Feb 02 2026
Globenewswire
Halper Sadeh LLC Investigates Multiple Companies for Potential Violations
Feb 02 2026
Globenewswire
Investor Rights Law Firm Investigates Multiple Companies
Jan 29 2026
Globenewswire
Monteverde Law Firm Investigates Multiple Acquisition Cases
Jan 29 2026
Globenewswire
Halper Sadeh LLC Investigates Potential Violations by Multiple Companies
Jan 28 2026
PRnewswire
Halper Sadeh LLC Investigates Penumbra and RAPT Transactions
Jan 27 2026
Globenewswire
Monteverde Law Firm Investigates Multiple Acquisition Cases
Jan 27 2026
Globenewswire
U.S. Millionaires Weighing Relocation: The Statistics
Jan 24 2026
Barron's
RAPT Therapeutics to be Sold to GSK for $58 Per Share
Jan 21 2026
Businesswire
Trump Threatens Tariffs, Market Sentiment Turns Neutral
Jan 21 2026
Benzinga
Halper Sadeh Investigates Calavo, RAPT, and Confluent Shareholder Rights
Jan 21 2026
PRnewswire
Show More News
